James Taylor is co-founder and CEO of Precision NanoSystems, a global leader ushering in the next wave of genetic medicines in infectious diseases, cancer and rare diseases. Previously, Taylor worked with the Centre for Drug Research and Development (now AdMare BioInnovations).